Hologic EBITDA 2006-2018 | HOLX
Hologic annual and quarterly EBITDA history from 2006 to 2018. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Hologic EBITDA for the quarter ending September 30, 2018 was $0.218B, a 5.09% decline year-over-year.
- Hologic EBITDA for the twelve months ending September 30, 2018 was $0.242B, a 86.68% decline year-over-year.
- Hologic 2018 annual EBITDA was $0.242B, a 86.68% decline from 2017.
- Hologic 2017 annual EBITDA was $1.819B, a 79.43% increase from 2016.
- Hologic 2016 annual EBITDA was $1.014B, a 7.13% increase from 2015.
| Hologic Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $242 |
| 2017 | $1,819 |
| 2016 | $1,014 |
| 2015 | $947 |
| 2014 | $803 |
| 2013 | $727 |
| 2012 | $465 |
| 2011 | $679 |
| 2010 | $441 |
| 2009 | $597 |
| 2008 | $-25 |
| 2007 | $179 |
| 2006 | $66 |
| 2005 | $40 |
| Hologic Quarterly EBITDA (Millions of US $) |
|
|---|---|
| Q4 2018 | $218 |
| Q3 2018 | $254 |
| Q2 2018 | $-485 |
| Q1 2017 | $255 |
| Q4 2017 | $230 |
| Q3 2017 | $233 |
| Q2 2017 | $1,095 |
| Q1 2016 | $261 |
| Q4 2016 | $262 |
| Q3 2016 | $260 |
| Q2 2016 | $250 |
| Q1 2015 | $242 |
| Q4 2015 | $248 |
| Q3 2015 | $237 |
| Q2 2015 | $236 |
| Q1 2014 | $226 |
| Q4 2014 | $223 |
| Q3 2014 | $210 |
| Q2 2014 | $180 |
| Q1 2013 | $189 |
| Q4 2013 | $214 |
| Q3 2013 | $190 |
| Q2 2013 | $132 |
| Q1 2012 | $191 |
| Q4 2012 | $77 |
| Q3 2012 | $157 |
| Q2 2012 | $87 |
| Q1 2011 | $144 |
| Q4 2011 | $152 |
| Q3 2011 | $151 |
| Q2 2011 | $231 |
| Q1 2010 | $145 |
| Q4 2010 | $6 |
| Q3 2010 | $153 |
| Q2 2010 | $136 |
| Q1 2009 | $146 |
| Q4 2009 | $146 |
| Q3 2009 | $150 |
| Q2 2009 | $141 |
| Q1 2008 | $160 |
| Q4 2008 | $-43 |
| Q3 2008 | $153 |
| Q2 2008 | $151 |
| Q1 2007 | $-286 |
| Q4 2007 | $54 |
| Q3 2007 | $48 |
| Q2 2007 | $42 |
| Q1 2006 | $35 |
| Q4 2006 | $15 |
| Q3 2006 | $22 |
| Q2 2006 | $19 |
| Q1 2005 | $10 |
| Q4 2005 | $13 |
| Q3 2005 | $11 |
| Q2 2005 | $9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.427B | $3.218B |
| Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.457B | 22.01 |
| Intuitive Surgical (ISRG) | United States | $58.919B | 57.97 |
| Edwards Lifesciences (EW) | United States | $32.745B | 35.04 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.185B | 14.32 |
| IDEXX Laboratories (IDXX) | United States | $17.009B | 48.58 |
| ABIOMED (ABMD) | United States | $14.599B | 104.90 |
| DexCom (DXCM) | United States | $13.065B | 0.00 |
| Teleflex (TFX) | United States | $11.433B | 25.95 |
| Varian Medical Systems (VAR) | United States | $11.421B | 28.42 |
| STERIS (STE) | United Kingdom | $9.401B | 24.94 |
| Masimo (MASI) | United States | $6.157B | 39.92 |
| Penumbra (PEN) | United States | $4.736B | 285.98 |
| LivaNova (LIVN) | United Kingdom | $4.387B | 28.16 |
| Globus Medical (GMED) | United States | $4.190B | 26.26 |
| Integra LifeSciences Holdings (IART) | United States | $3.928B | 19.13 |
| Wright Medical Group (WMGI) | Netherlands | $3.581B | 0.00 |
| Cantel Medical (CMD) | United States | $3.276B | 32.31 |
| Inogen (INGN) | United States | $3.121B | 67.36 |
| Integer Holdings (ITGR) | United States | $2.609B | 21.83 |
| Tandem Diabetes Care (TNDM) | United States | $2.522B | 0.00 |
| Glaukos (GKOS) | United States | $2.123B | 0.00 |
| Halyard Health (AVNS) | United States | $2.108B | 18.99 |
| OPKO Health (OPK) | United States | $2.088B | 0.00 |
| Nevro (NVRO) | United States | $1.261B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.134B | 180.50 |
| Luminex (LMNX) | United States | $1.133B | 41.00 |
| Natus Medical (BABY) | United States | $1.121B | 23.56 |
| Pacific Biosciences Of California (PACB) | United States | $1.083B | 0.00 |
| CryoLife (CRY) | United States | $1.054B | 91.93 |
| Orthofix (OFIX) | United States | $0.964B | 27.83 |
| Intersect ENT (XENT) | United States | $0.873B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.867B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.832B | 49.20 |
| AngioDynamics (ANGO) | United States | $0.772B | 25.05 |
| ViewRay (VRAY) | United States | $0.716B | 0.00 |
| Veracyte (VCYT) | United States | $0.646B | 0.00 |
| TransEnterix (TRXC) | United States | $0.590B | 0.00 |
| AxoGen (AXGN) | United States | $0.560B | 0.00 |
| Si-Bone (SIBN) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.409B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.396B | 0.00 |
| Sientra (SIEN) | United States | $0.381B | 0.00 |
| Fluidigm (FLDM) | United States | $0.340B | 0.00 |
| Accuray (ARAY) | United States | $0.336B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.335B | 0.00 |
| IRadimed (IRMD) | United States | $0.287B | 74.97 |
| SeaSpine Holdings (SPNE) | United States | $0.278B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.261B | 41.20 |
| Nuvectra (NVTR) | United States | $0.260B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.248B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.228B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.227B | 39.13 |
| Helius Medical Technologies (HSDT) | United States | $0.217B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.164B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.132B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.120B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.106B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.079B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.073B | 0.00 |
| EDAP TMS (EDAP) | France | $0.072B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.071B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.064B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.063B | 0.00 |
| Vermillion (VRML) | United States | $0.054B | 0.00 |
| Electromed (ELMD) | United States | $0.042B | 20.00 |
| OBALON THERPTCS (OBLN) | United States | $0.040B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.039B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.037B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.036B | 0.00 |
| ConforMIS (CFMS) | United States | $0.034B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.030B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.024B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.020B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.020B | 0.00 |
| Neovasc (NVCN) | Canada | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 72.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 10.96 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Amedica (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
